Successful treatment with high-dose intravenous immunoglobulin in a patient with spontaneous inhibitor to factor VIII
- 1 February 1986
- journal article
- case report
- Published by Springer Nature in Annals of Hematology
- Vol. 52 (2) , 123-126
- https://doi.org/10.1007/bf00321075
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- INTRAVENOUS IgG FOR PATIENTS WITH SPONTANEOUS INHIBITOR TO FACTOR VIIIThe Lancet, 1985
- ANTI-IDIOTYPIC SUPPRESSION OF AUTOANTIBODIES TO FACTOR VIII (ANTIHAEMOPHILIC FACTOR) BY HIGH-DOSE INTRAVENOUS GAMMAGLOBULINThe Lancet, 1984
- Intravenous immunoglobulin therapy: New aspects and outlookAnnals of Hematology, 1984
- Haemophilia due to factor VIII inhibitors in a patient suffering from an autoimmune disease: Treatment with intravenous immunoglobulinAnnals of Hematology, 1984
- The treatment of haemophilia a inhibitor with high dose intravenous immunoglobulinAnnals of Hematology, 1984
- Specific and nonspecific mechanisms of action of immunoglobulin G in therapy of idiopathic thrombocytopenic purpura (ITP)Annals of Hematology, 1984
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOODThe Lancet, 1981
- A Survey of 215 Non-Hemophilic Patients with Inhibitors to Factor VIIIThrombosis and Haemostasis, 1981
- Plasma exchange and human factor VIII concentrate in managing haemophilia A with factor VIII inhibitors.BMJ, 1980
- Factor VIII Antibodies in Rheumatoid ArthritisArchives of internal medicine (1960), 1980